BioCentury | Nov 16, 2018
Financial News

Swiss cancer play Amal eyes clinic following €21.2M tranche

...raised in the round to €29 million ($32.9 million). Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund...
...a modulable multiple-antigen cargo. Amal Therapeutics S.A., Geneva, Switzerland Jaime De Leon Amal Therapeutics S.A. BioMedPartners Boehringer Ingelheim Venture Fund Helsinn Investment Fund High-Tech...
BioCentury | Nov 12, 2018
Financial News

Swiss cancer play Amal eyes clinic following €21.2M tranche

...raised in the round to €29 million ($32.9 million). Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund...
...TLR) peptide agonist adjuvant and a modulable multiple-antigen cargo. Jaime De Leon Amal Therapeutics S.A. BioMedPartners Boehringer Ingelheim Venture Fund Helsinn Investment Fund High-Tech...
BioCentury | Sep 21, 2018
Company News

Diagnostic companies Cancer Genetics, NovellusDx merging

...see "Signal Mapping" ). The companies said existing NovellusDx shareholders including OrbiMed Israel Partners, Pontifax, Helsinn Investment Fund...
BioCentury | Sep 14, 2018
Financial News

OncoResponse to move into clinic with $40M series B

...as did existing investors Alexandria Venture Investments, Arch Venture Partners, HT Family Office, Canaan Partners, Helsinn Investment Fund...
BioCentury | Sep 11, 2018
Financial News

OncoResponse to move into clinic with $40M series B

...as did existing investors Alexandria Venture Investments, Arch Venture Partners, HT Family Office, Canaan Partners, Helsinn Investment Fund...
BioCentury | Jan 12, 2018
Financial News

Personal Genome raises $75M series B round

...Bristol-Myers Squibb Co. (NYSE:BMY) and New Enterprise Associates (NEA). Inova Strategic Investments, Co-win Healthcare Fund, Helsinn Investment Fund...
BioCentury | Jan 5, 2018
Financial News

Personal Genome raises $75M B round

...Bristol-Myers Squibb Co. (NYSE:BMY) and New Enterprise Associates (NEA). Inova Strategic Investments, Co-win Healthcare Fund, Helsinn Investment Fund...
BioCentury | Sep 8, 2017
Financial News

Amal raises $9.5M in first close of series B round

...first close of a series B round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund...
BioCentury | May 12, 2017
Financial News

Aadi raises $23M in series A

...a series A round led by Hermed Capital. Celgene Corp. (NASDAQ:CELG), Vivo Capital, Decheng Capital, Helsinn Investment Fund...
BioCentury | May 8, 2017
Financial News

Aadi raises $23M series A round

...A led by Hermed Capital. Also participating were Celgene Corp. (NASDAQ:CELG), Vivo Capital, Decheng Capital, Helsinn Investment Fund...
Items per page:
1 - 10 of 13
BioCentury | Nov 16, 2018
Financial News

Swiss cancer play Amal eyes clinic following €21.2M tranche

...raised in the round to €29 million ($32.9 million). Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund...
...a modulable multiple-antigen cargo. Amal Therapeutics S.A., Geneva, Switzerland Jaime De Leon Amal Therapeutics S.A. BioMedPartners Boehringer Ingelheim Venture Fund Helsinn Investment Fund High-Tech...
BioCentury | Nov 12, 2018
Financial News

Swiss cancer play Amal eyes clinic following €21.2M tranche

...raised in the round to €29 million ($32.9 million). Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund...
...TLR) peptide agonist adjuvant and a modulable multiple-antigen cargo. Jaime De Leon Amal Therapeutics S.A. BioMedPartners Boehringer Ingelheim Venture Fund Helsinn Investment Fund High-Tech...
BioCentury | Sep 21, 2018
Company News

Diagnostic companies Cancer Genetics, NovellusDx merging

...see "Signal Mapping" ). The companies said existing NovellusDx shareholders including OrbiMed Israel Partners, Pontifax, Helsinn Investment Fund...
BioCentury | Sep 14, 2018
Financial News

OncoResponse to move into clinic with $40M series B

...as did existing investors Alexandria Venture Investments, Arch Venture Partners, HT Family Office, Canaan Partners, Helsinn Investment Fund...
BioCentury | Sep 11, 2018
Financial News

OncoResponse to move into clinic with $40M series B

...as did existing investors Alexandria Venture Investments, Arch Venture Partners, HT Family Office, Canaan Partners, Helsinn Investment Fund...
BioCentury | Jan 12, 2018
Financial News

Personal Genome raises $75M series B round

...Bristol-Myers Squibb Co. (NYSE:BMY) and New Enterprise Associates (NEA). Inova Strategic Investments, Co-win Healthcare Fund, Helsinn Investment Fund...
BioCentury | Jan 5, 2018
Financial News

Personal Genome raises $75M B round

...Bristol-Myers Squibb Co. (NYSE:BMY) and New Enterprise Associates (NEA). Inova Strategic Investments, Co-win Healthcare Fund, Helsinn Investment Fund...
BioCentury | Sep 8, 2017
Financial News

Amal raises $9.5M in first close of series B round

...first close of a series B round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund...
BioCentury | May 12, 2017
Financial News

Aadi raises $23M in series A

...a series A round led by Hermed Capital. Celgene Corp. (NASDAQ:CELG), Vivo Capital, Decheng Capital, Helsinn Investment Fund...
BioCentury | May 8, 2017
Financial News

Aadi raises $23M series A round

...A led by Hermed Capital. Also participating were Celgene Corp. (NASDAQ:CELG), Vivo Capital, Decheng Capital, Helsinn Investment Fund...
Items per page:
1 - 10 of 13